NIOSH R21 WTC Asthma
NCT07222501
Summary
Aim 2: Conduct a pilot RCT of SaMBA-WTC to determine feasibility and preliminary impact in preparation for a fully powered trial. (7M-24M) The investigators will conduct a pilot RCT (n=58) of the SaMBA-WTC model vs. an attention control. Data will be collected on the primary outcomes (asthma control \[asthma control test, ACT\], medication use, inhaler technique) as well as on other secondary outcomes including measures of physical function, self-management behaviors, feasibility and fidelity at baseline, at intervention completion at 3 months, and for sustainability at 6 months. This project will prepare the team for all aspects of a subsequent larger efficacy trial of SaMBA-WTC.
Eligibility
Inclusion Criteria: * Age \>=21 years; * English or Spanish speaking; * World Trade Center-certified asthma; * on asthma controller medications (as needed or standing); * uncontrolled asthma. Exclusion Criteria: * Physician's diagnosis of dementia, * COPD or other chronic pulmonary disease, * \>15 pack-years history of smoking to avoid enrolling WTC responders with undiagnosed COPD.
Conditions1
Locations1 site
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT07222501